OncoImmune announced the completion of a $56 million Series B financing round. The financing was co-led by HM ...
California’s ProgenaBiome recently received the greenlight from the U.S. Food and Drug Administration (FDA) for two
Rain Therapeutics a privately held, clinical stage biotechnology company focused on targeted therapies for patients
Inversago Pharma announced it has secured a US$35 million Series B financing round led by Forbion, with ...
Daina Graybosch, a top life science research analyst at SVB Leerink covering Immuno-Oncology, recently communicated
Investor Watch Series
No results found.